Jason Werner - Oct 2, 2023 Form 4 Insider Report for ALIMERA SCIENCES INC (ALIM)

Role: Chief Operating Officer
Signature: /s/ Jason Werner
Stock symbol: ALIM
Transactions as of: Oct 2, 2023
Transactions value $: $0
Form type: 4
Date filed: 10/4/2023, 04:45 PM
Previous filing: May 19, 2023
Next filing: Mar 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALIM	Common Stock	Award	$0	+225K		$0.00	225K	Oct 2, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALIM	Stock Option (Right to Buy)	Award	$0	+225K		$0.00	225K	Oct 2, 2023	Common Stock	225K	$2.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSUs vest in four equal annual installments beginning October 2, 2023, with the first annual installment vesting on October 2, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the grant date through the applicable anniversary thereof.
F2	The options shall vest and become exercisable with respect to twenty-five percent (25%) of the shares after twelve (12) months of the Reporting Person's continuous service commencing on October 2, 2023, and the balance will vest in equal monthly installments over the next thirty-six (36) months of the Reporting Person's continuous service with the Issuer thereafter, with the final installment adjusted as necessary to avoid any fractional shares in any installment.

Content

Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSUs vest in four equal annual installments beginning October 2, 2023, with the first annual installment vesting on October 2, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the grant date through the applicable anniversary thereof.

The options shall vest and become exercisable with respect to twenty-five percent (25%) of the shares after twelve (12) months of the Reporting Person's continuous service commencing on October 2, 2023, and the balance will vest in equal monthly installments over the next thirty-six (36) months of the Reporting Person's continuous service with the Issuer thereafter, with the final installment adjusted as necessary to avoid any fractional shares in any installment.